Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Institute of Neuropsychiatry, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
BMC Neurol. 2019 Jul 22;19(1):175. doi: 10.1186/s12883-019-1386-3.
Elevated levels of plasma D-dimer increase the risk of ischemic stroke, stroke severity, and the progression of stroke status, but the association between plasma D-dimer level and functional outcome is unclear. The aim of this study is to investigate whether plasma D-dimer level is a determinant of short-term poor functional outcome in patients with acute ischemic stroke (AIS).
This prospective study included 877 Chinese patients with AIS admitted to Renmin Hospital of Wuhan University within 72 h of symptom onset. Patients were categorized by plasma D-dimer level: Quartile 1(≤0.24 mg/L), Quartile 2 (0.25-0.56 mg/L), Quartile 3 (0.57-1.78 mg/L), and Quartile 4 (> 1.78 mg/L). The medical record of each patient was reviewed, and demographic, clinical, laboratory and neuroimaging information was abstracted. Functional outcome at 90 days was assessed with the modified Rankin Scale.
Poor outcome was present in 302 (34.4%) of the 877 patients that were included in the study (mean age, 64 years; male, 68.5%). After adjustment for potential confounding variables, higher plasma D-dimer level on admission was associated with poor outcome (adjusted odds ratio 2.257, 95% confidence interval 1.349-3.777 for Q4:Q1; P trend = 0.004). According to receiver operating characteristic (ROC) analysis, the best discriminating factor for poor outcome was a plasma D-dimer level ≥ 0.315 mg/L (area under the ROC curve 0.657; sensitivity 83.8%; specificity 41.4%).
Elevated plasma D-dimer levels on admission are significantly associated with poor outcome after admission for AIS, suggesting the potential role of plasma D-dimer level as a predictive marker for short-term poor outcome in patients with AIS.
血浆 D-二聚体水平升高会增加缺血性脑卒中、脑卒中严重程度和脑卒中进展的风险,但血浆 D-二聚体水平与功能预后的关系尚不清楚。本研究旨在探讨急性缺血性脑卒中(AIS)患者入院时的血浆 D-二聚体水平是否可预测短期不良功能预后。
这是一项前瞻性研究,纳入了 877 例发病 72 小时内就诊于武汉大学人民医院的中国 AIS 患者。根据血浆 D-二聚体水平将患者分为 4 个四分位组:第 1 四分位组(≤0.24mg/L)、第 2 四分位组(0.25-0.56mg/L)、第 3 四分位组(0.57-1.78mg/L)和第 4 四分位组(>1.78mg/L)。回顾性分析每位患者的病历资料,提取人口统计学、临床、实验室和神经影像学信息。采用改良 Rankin 量表评估 90 天的功能预后。
本研究共纳入了 877 例患者,其中 302 例(34.4%)预后不良(平均年龄 64 岁,男性占 68.5%)。调整潜在混杂因素后,入院时较高的血浆 D-二聚体水平与不良预后相关(第 4 四分位组比第 1 四分位组调整后比值比 2.257,95%置信区间 1.349-3.777;趋势 P=0.004)。根据受试者工作特征(ROC)分析,预测不良预后的最佳分界值为血浆 D-二聚体水平≥0.315mg/L(ROC 曲线下面积 0.657;敏感度 83.8%,特异度 41.4%)。
入院时升高的血浆 D-二聚体水平与 AIS 患者入院后不良预后显著相关,提示血浆 D-二聚体水平可能是 AIS 患者短期不良预后的预测指标。